ATP6V0A2

ATP6V0A2 encodes the a2 isoform of the V0 sector of the vacuolar H+-ATPase, functioning both as a proton-translocation subunit that drives organelle acidification and as a pH-sensitive scaffold that recruits the Arf GEF ARNO and Arf6 to early endosomes to regulate endocytic trafficking between early and late compartments (PMID:16415858). At the Golgi apparatus, ATP6V0A2 is required for normal cisternae architecture, vesicular trafficking, N- and O-glycoprotein processing, and tropoelastin secretion; its loss causes Golgi distension, intracellular tropoelastin retention, impaired elastin deposition, elevated TGF-β signaling, and increased apoptosis of elastogenic cells (PMID:19321599, PMID:22773132). High-resolution cryo-EM structures place the a-subunit within the Vo membrane complex, where a luminal glycan coat formed by glycolipids and glycosylated Vo subunits contributes to V-ATPase folding, localization, and stability (PMID:33065002). Loss-of-function mutations in ATP6V0A2 cause autosomal recessive cutis laxa type II and wrinkly skin syndrome with congenital disorder of glycosylation type II (PMID:18157129).

1. 2006 High

   Identification of the a2 isoform as a pH-sensitive scaffold on early endosomes resolved how V-ATPase acidification is coupled to vesicular coat recruitment: a2 directly binds the Arf GEF ARNO in an acidification-dependent manner, and disruption of this interaction blocks trafficking from early to late endosomes.

   Evidence Reciprocal co-immunoprecipitation, dominant-negative constructs, pharmacological V-ATPase inhibition, and endocytosis assays in mammalian cells

   PMID:16415858

   Open questions at the time

   • Structural basis of the pH-dependent a2–ARNO interaction is unknown
   • Whether a2 scaffolding function is independent of its proton-translocating role has not been dissected
   • Contribution of other a-subunit isoforms to endosomal ARNO recruitment was not tested
2. 2007 High

   Human genetics established that a2 is essential for Golgi-based glycoprotein processing: loss-of-function ATP6V0A2 mutations cause ARCL2/wrinkly skin syndrome with CDG-II-type glycosylation defects and impaired Golgi trafficking, linking organelle acidification to a specific Mendelian connective-tissue disorder.

   Evidence Patient mutation sequencing, serum glycoprotein analysis (isoelectric focusing), and fibroblast trafficking assays across multiple affected families

   PMID:18157129

   Open questions at the time

   • Which specific glycosyltransferase steps are pH-sensitive and disrupted by a2 loss was not determined
   • Genotype–phenotype correlation across different ATP6V0A2 mutations remained incomplete
3. 2009 High

   Mechanistic dissection showed that a2 specifically controls tropoelastin secretion and elastin assembly: its loss causes Golgi distension, tropoelastin retention in swollen Golgi cisternae, aberrant lysosomes, reduced extracellular elastin deposition, and increased apoptosis, while fibrillin-1 and lysyl oxidase pathways are unaffected.

   Evidence siRNA knockdown and ARCL2 patient fibroblasts analyzed by pulse-chase secretion assays, insoluble elastin quantification, electron microscopy, and TUNEL apoptosis assay

   PMID:19321599

   Open questions at the time

   • Why tropoelastin is selectively sensitive to a2 loss while other secreted ECM proteins are not is unexplained
   • Whether apoptosis is a direct consequence of Golgi dysfunction or secondary to aggregated tropoelastin toxicity is unresolved
4. 2012 High

   Golgi localization of a2 was directly demonstrated and its role in Golgi membrane dynamics distinguished from other ARCL genes: a2-deficient fibroblasts show delayed brefeldin A-induced Golgi collapse and elevated TGF-β1 secretion, revealing crosstalk between Golgi pH regulation and growth factor signaling.

   Evidence Immunostaining, brefeldin A collapse kinetics, TGF-β ELISA, and comparison with GORAB- and PYCR1-deficient fibroblasts

   PMID:22773132

   Open questions at the time

   • Mechanism by which a2 loss elevates TGF-β signaling (mis-sorting of TGF-β receptors vs. impaired lysosomal degradation) is unresolved
   • Whether the Golgi-collapse delay reflects altered membrane fusion or fission was not distinguished
5. 2020 High

   Cryo-EM structures of the intact human V-ATPase resolved the position of the a-subunit within the Vo membrane sector and revealed that a luminal glycan coat and bound phospholipids are critical for complex assembly, stability, and localization, providing the first atomic-level context for pathogenic ATP6V0A2 mutations.

   Evidence Cryo-EM at up to 2.9 Å resolution in three rotational states with mass spectrometry-assisted identification of glycolipids and phospholipids

   PMID:33065002

   Open questions at the time

   • No isoform-specific structure of the a2 subunit has been determined
   • How a2-specific sequences determine Golgi/early-endosome targeting versus other a-isoform targeting is structurally unexplained
   • Impact of specific ARCL2 missense mutations on Vo assembly and rotation has not been modeled

• Key open questions include how a2 isoform-specific sequences determine its dual Golgi/early-endosome targeting, whether a2's scaffolding function for ARNO/Arf6 can be separated from its proton-translocation role, and by what mechanism a2 loss selectively impairs tropoelastin secretion and activates TGF-β signaling.
• No reconstituted system has tested a2 scaffolding independently of proton pumping
• Tissue-specific compensation by other a-subunit isoforms is poorly understood
• Structural basis for selective tropoelastin retention in a2-null Golgi is unknown